Skip to main content

The First and Only Mealtime Insulin Patch that Can Be Worn for Up to 7 Days

CeQur Simplicity is a wearable insulin patch that delivers injection-free mealtime insulin. It's not a pen. It's not a pump.

Using a tiny, flexible cannula, you can deliver rapid-acting insulin under your skin. It changes the way you dose for meals and correction boluses, eliminating the need for multiple daily injections.1

Get Started Learn About Mealtime Insulin

Now Available in Both 2U and 1U Dosing Options

CeQur Simplicity 2U wearable insulin patch

2U Wearable Insulin Patch

For patients on larger volumes of rapid-acting insulin who can handle 2-unit dosing increments.

CeQur Simplicity 1U wearable insulin patch

1U Wearable Insulin Patch

For insulin-sensitive patients who have lower rapid-acting insulin needs and dose in 1-unit increments.

On-Demand, Wearable Insulin with CeQur Simplicity on Your Side

CeQur Simplicity on the Abdomen

Convenient

One click delivers 1 unit or
2 units of rapid-acting insulin

Discreet

Compact, lightweight, and easily hidden under your clothes

CeQur Simplicity Under the Shirt

Injection-Free

Soft cannula, less pain, no hassle2
  • 1 patch replaces up to 21 injections over 7 days
  • Each patch holds 240 units of rapid acting insulin
  • Clinically shown to reduce A1C and improve time-in-range2,3
  • Click and dose in any situation
  • Deliver rapid-acting insulin under your skin using a tiny, flexible cannula
  • Injection-free
  • Comfortable to wear
  • Water-resistant
Get Started Today

Simple Dosing

You can click and dose in any situation. There is no complicated programming, no reliance on digital technology, and no exposed tubing. It’s simple, on-demand, one-click dosing for mealtime insulin and bolus correction.

Comfortable to Wear

CeQur Simplicity stays in place for up to 7 days, no matter your activity level.2  With rounded corners, a thin, low-profile design, and a flexible cannula, it lets you forget all about it until it’s time to dose.

Ease the Burden

No more multiple daily injections. One CeQur Simplicity patch replaces up to twenty-one mealtime injections, lessening the pain and burden that can be experienced with pens and syringes.2

Safety First

There’s no guesswork. You’ll feel and hear a “click” when each dose is given. The two-button dosing mechanism prevents accidental dosing during activities and sleep.4

Water-Resistant

CeQur Simplicity stands up to exercising, bathing, swimming, and other physical activities, with less interference and added convenience.4

CeQur Simplicity is Clinically Shown to Keep Your A1C and Time-in-Range (TIR) in Check, Which Reduces the Risk of Long-Term Health Complications2,3

Take back glycemic control

After 24 weeks, CeQur Simplicity users increased TIR by 50%3

Flatten blood sugar spikes

88% of people followed their insulin regimen better using CeQur Simplicity1

Achieve your targets

CeQur Simplicity users decreased their A1C by an average of 1.7% after 24 weeks2

Results were comparable to pens. Consistent A1C <7% supports HEDIS Comprehensive Diabetes Care measure.

References

1. Zraick V, Dreon D, Nalk R, Shearer D, Crawford S, Bradford J, Levy B. 2016. Patient User Experience Evaluation of Bolus Patch Insulin Delivery System. Poster presented at the American Diabetes Association’s 76th Scientific Sessions. Abstract 995-P. New Orleans, LA, USA.

2. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.

3. Bergenstal RM, Johnson ML, Aroda VR, et al. Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. J Diabetes Sci Technol. 2022;16(5):1167-1173.

4. Dreon D, Hannon T, Cross B, Carter B, Mercer N, Nguyen J, Tran A , Melendez P, Morales N, Nelson J, Tan M. 2018. Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System. Journal of Diabetes Science and Technology. 12(4):817-827.